CAXTON CORP - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 68 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$5,684,000
+8.8%
21,842,662
+0.3%
6.41%
-11.1%
Q1 2016$5,225,000
-31.8%
21,771,847
+0.1%
7.21%
-77.6%
Q4 2015$7,659,000
-88.1%
21,758,894
-41.4%
32.13%
-63.1%
Q3 2015$64,599,000
-21.9%
37,126,140
+0.0%
87.13%
-0.5%
Q2 2015$82,762,000
+15.1%
37,113,186
+0.1%
87.59%
+2.1%
Q1 2015$71,893,000
-10.2%
37,058,136
+22.7%
85.78%
-6.8%
Q4 2014$80,025,000
-12.0%
30,197,945
+0.0%
92.06%
-1.6%
Q3 2014$90,887,000
-25.7%
30,194,898
+1.0%
93.55%
-0.7%
Q2 2014$122,258,000
-1.0%
29,891,849
+4.4%
94.25%
+0.0%
Q1 2014$123,436,000
-17.7%
28,639,349
-0.0%
94.21%
-1.1%
Q4 2013$150,057,000
+0.6%
28,641,849
+21.2%
95.29%
-4.6%
Q3 2013$149,133,000
+26.5%
23,634,349
+0.0%
99.87%
+0.1%
Q2 2013$117,923,000
-33.2%
23,631,849
+15.1%
99.78%
+0.0%
Q1 2013$176,554,000
-4.6%
20,529,561
+0.0%
99.77%
+25.4%
Q4 2012$185,156,00020,527,27779.57%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q1 2016
NameSharesValueWeighting ↓
CAXTON CORP 37,061,186$82,646,00087.47%
Geller Advisors LLC 187,323$418,0000.24%
IRONWOOD INVESTMENT MANAGEMENT LLC 430,749$961,0000.22%
Verity Asset Management, Inc. 81,694$182,0000.16%
CAXTON CORP 52,000$116,0000.12%
Catalyst Capital Advisors LLC 400,000$892,0000.10%
Cutler Capital Management, LLC 72,500$161,0000.07%
STONERIDGE INVESTMENT PARTNERS LLC 239,202$533,0000.07%
SECOR Capital Advisors, LP 35,087$78,0000.03%
Roundview Capital LLC 29,100$65,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders